Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > Vivus and Arena: A Tale of Dueling FDA Panel Minutes

FDAnews Drug Daily Bulletin

June 27, 2012 | Vol. 9 No. 126

Vivus and Arena: A Tale of Dueling FDA Panel Minutes

The FDA has published the official minutes summarizing the discussion and outcomes of two advisory panels that reviewed the respective weight-loss drugs from Vivus and Arena Pharmaceuticals.
The Street

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Full Issue Experts Spar Over FDA Meeting To Re-Evaluate GSK’s Avandia Shionogi Gets Untitled Letter After Refusing To Conduct Postmarketing Study J&J Eyes Growth Spurt With 10 New Product Launches Planned by 2017

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.